Oramed Pharma
ORMP----
Forecast & RatingOnly 1 analyst currently covers Oramed Pharma (ORMP.US), with a price target of $6.25. The sample is very small, so treat this as a reference only. Data as of Jun 18, 2026; this does not constitute investment advice.
Jun 18, 2026Price forecast
$6.2550.24%
Forecast & Rating-
0analysts
Target price forecast
Forecast baselineJul 26, 2026
Forecast met41.4%
Stock price$4.16
Average forecast price$6.3
Highest forecast price$6
Lowest forecast price$6
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.